Medical Devices: Page 162
-
Improper inhaler use common among majority of asthmatics: study
Research funded by digital therapeutics company Propeller Health — recently picked up by ResMed — used sensors attached to inhalers to find 84% of asthmatics may not properly administer their medication.
By Maria Rachal • Feb. 22, 2019 -
FDA rule on device study practices comes into force
The final rule mandates the use of good clinical practices by sponsors of trials based outside the U.S.
By Nick Paul Taylor • Feb. 22, 2019 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Japan agrees to reimburse LivaNova's sutureless aortic heart valve
The insurance coverage decision should help the company grow sales of its Perceval device.
By Nick Paul Taylor • Feb. 22, 2019 -
Philips' camera-guided digital imaging system gets FDA OK
The nod comes after Philips reported fourth quarter growth in image-guided therapy, ultrasound and diagnostic imaging.
By Meg Bryant • Feb. 21, 2019 -
First commercial epilepsy patient gets Medtronic deep brain stimulation device
The device, which received premarket approval from FDA in April, aims to reduce how often patients experience partial-onset seizures by delivering electrical stimulation to certain areas in the brain.
By David Lim • Feb. 21, 2019 -
Abbott and Novo Nordisk plan to link diabetes devices
The connected insulin dosing pens from Novo Nordisk will share data with digital platforms connected to Abbott's FreeStyle Libre continuous glucose monitoring system, though the partnership is non-exclusive.
By Maria Rachal • Feb. 21, 2019 -
Durable medical equipment spending to spike $36.9B by 2027, CMS says
The projected growth in durable medical equipment spending comes as CMS continues to implement a potentially costly overhaul of its coverage for DME.
By Rebecca Pifer • Feb. 20, 2019 -
Swiss regulator weighs in on textured breast implants
Swissmedic is the latest national authority to flag a lymphoma that may be tied to breast implants.
By Susan Kelly • Feb. 20, 2019 -
Intuitive gains FDA clearance for Ion lung catheter
The robot-assisted surgery pioneer said it plans a measured U.S. rollout of the system with customer shipments beginning in the second quarter.
By Susan Kelly • Feb. 20, 2019 -
Medtronic and J&J lost spine share to pure-play rivals in Q4, analysts say
Globus Medical, NuVasive and Stryker's K2M drew business away from the medtech giants, mirroring a trend seen the past two years.
By Nick Paul Taylor • Feb. 20, 2019 -
FDA grants breakthrough status to concussion-detecting VR headset
The SyncThink device analyzes the wearer's eye movements. The medtech has deals with the Golden State Warriors and hospitals including Mass General.
By Nick Paul Taylor • Feb. 20, 2019 -
FDA proposes new channel for giving feedback on inspections
The agency is looking to create a process for providing nonbinding feedback to medical device companies that it expects to help speed corrective actions on safety and quality issues.
By Susan Kelly • Feb. 19, 2019 -
FDA clarifies pathway for devices used in regenerative medicine
The final guidance document covers instruments, machines and implants used in conjunction with cell-based and gene therapies.
By Susan Kelly • Feb. 19, 2019 -
Medtronic recalls pacemakers due to software error
The medtech giant is recalling 13,440 of the devices in the United States because the defect could result in a break in pacing function.
By Susan Kelly • Feb. 19, 2019 -
Medtronic posts beat-and-raise Q3 despite tumbling heart failure sales
Heart failure sales fell more than 40% as Abbott's HeartMate 3 took a big chunk of market share. Separately, the company reported FDA breakthrough designation for its personalized closed loop insulin pump system.
By Nick Paul Taylor • Feb. 19, 2019 -
Deep Dive
4 main takeaways from HIMSS19
Digest the biggest health IT conference of the year with this roundup of what grabbed the attention of more than 43,000 health execs, policymakers and academics.
By David Lim , Rebecca Pifer • Feb. 15, 2019 -
FDA orders doctor to stop marketing unapproved breast augmentation device
The warning letter comes amid increased scrutiny of breast implants by regulators globally, with reported cases of adverse events linked to the devices on the rise.
By Susan Kelly • Feb. 15, 2019 -
Boston Scientific-BTG deal faces FTC holdup
The embolization beads businesses are at the heart of U.S. anti-trust regulators' concerns.
By Maria Rachal • Feb. 15, 2019 -
HIMSS19: Doctors don't know what to do with data from wearables
"If you present this data and bring in your device and say 'here I have this heart rate data from the last month' we're going to say, 'that's great, but we don't know what it really means,'" a Mayo Clinic medical director said.
By David Lim • Feb. 15, 2019 -
HIMSS19: Medical device cybersecurity still top concern
The WannaCry attack highlighted the need for hospitals to have a better understanding of medical devices in their inventory in order to better be equipped to respond to cyberattacks.
By David Lim • Feb. 15, 2019 -
New medtech initiatives to be funded amid 9% FDA budget boost
The agency would receive $269 million more in funding this year from the appropriations package that passed Congress, with allocations for initiatives addressing medtech manufacturing and digital health.
By Maria Rachal • Feb. 15, 2019 -
Insulet gains 'ACE' label for interoperable insulin pump, following Tandem
Diabetes tech company Insulet said Monday FDA granted its commercialized Omnipod Dash system clearance as an alternate controller enabled infusion pump.
By Nick Paul Taylor • Updated Sept. 23, 2019 -
HIMSS19: CMS plans to host AI challenge, innovation chief says
The goal of the initiative is to spur private interest in the tech, improve the government's grasp on healthcare data, eliminate unnecessary care and cut costs, Adam Boehler said.
By Rebecca Pifer • Feb. 14, 2019 -
Medical devices recalled from US jump in Q4
The more than 400% surge in recalled units was underpinned by a widespread action by BD.
By Nick Paul Taylor • Feb. 14, 2019 -
Software products face high-risk upclassing in Australia
The Therapeutic Goods Administration wants to significantly increase the regulatory burden on medical software, with some products potentially jumping from the lowest to highest risk category.
By Nick Paul Taylor • Feb. 14, 2019
Previous
